Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Titan Pharma (TTNP)

Titan Pharma (TTNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Titan Pharmaceuticals Faces Nasdaq Compliance Challenges with Reporting and Audit Committee Requirements

Titan Pharmaceuticals faces non-compliance notices from Nasdaq for delayed filings and audit committee requirements, planning corrective actions.Quiver AI SummaryTitan Pharmaceuticals, Inc. received a...

TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq

TTNP : 3.38 (+4.64%)
Stock Index Futures Tread Water as Investors Brace for Fed Minutes and Powell’s Speech

September S&P 500 E-Mini futures (ESU24) are up +0.01%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.09% this morning as market participants geared up for the release of the minutes of the...

ESU24 : 5,699.99s (-0.31%)
NQU24 : 19,808.01s (-0.21%)
ZIM : 18.29 (-0.49%)
AMD : 119.21 (+0.28%)
MCD : 292.68 (+0.84%)
HPQ : 32.94 (+1.48%)
LOW : 247.72 (+1.31%)
MDT : 81.03 (+1.30%)
KEYS : 163.22 (+2.11%)
TOL : 125.45 (+1.33%)
AS : 28.18 (+2.47%)
TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals: Q2 Earnings Snapshot

Titan Pharmaceuticals: Q2 Earnings Snapshot

TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals: Q1 Earnings Snapshot

Titan Pharmaceuticals: Q1 Earnings Snapshot

TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals: Q3 Earnings Snapshot

Titan Pharmaceuticals: Q3 Earnings Snapshot

TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals: Q2 Earnings Snapshot

Titan Pharmaceuticals: Q2 Earnings Snapshot

TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals Announces Board Expansion and Management Changes

/PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has expanded its Board of Directors (the "Board")...

TTNP : 3.38 (+4.64%)
Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant

/PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that the U.S. Food and Drug Administration ("FDA") has...

TTNP : 3.38 (+4.64%)
Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.

NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, Chief Executive Officer of Activist Investing LLC (together with its affiliates, “Activist...

TTNP : 3.38 (+4.64%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar